Angelo Di Santo

400 total citations
7 papers, 286 citations indexed

About

Angelo Di Santo is a scholar working on Infectious Diseases, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angelo Di Santo has authored 7 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Urology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angelo Di Santo's work include Urinary Bladder and Prostate Research (2 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper) and Renal cell carcinoma treatment (1 paper). Angelo Di Santo is often cited by papers focused on Urinary Bladder and Prostate Research (2 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper) and Renal cell carcinoma treatment (1 paper). Angelo Di Santo collaborates with scholars based in Italy, Lebanon and France. Angelo Di Santo's co-authors include Gabriele Gaziev, Enrico Finazzi Agrò, Valerio Iacovelli, Anastasios D. Asimakopoulos, Cosimo De Nunzio, Luca Topazio, Virgilio Evangelista, Sandra P. D’Angelo, Paola Patrignani and Maria G. Sciulli and has published in prestigious journals such as Circulation Research, Brain Research and Frontiers in Pharmacology.

In The Last Decade

Angelo Di Santo

6 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Di Santo Italy 6 105 86 63 62 42 7 286
Márcio A. F. de Godoy United States 14 80 0.8× 151 1.8× 112 1.8× 24 0.4× 158 3.8× 22 467
Matilde Marchetta Italy 8 54 0.5× 16 0.2× 48 0.8× 24 0.4× 82 2.0× 9 346
Hongzoo Park South Korea 12 73 0.7× 59 0.7× 52 0.8× 12 0.2× 161 3.8× 46 379
D. Gordon United Kingdom 5 15 0.1× 22 0.3× 37 0.6× 10 0.2× 39 0.9× 7 333
Toshihisa Tomoda Japan 11 84 0.8× 49 0.6× 17 0.3× 9 0.1× 66 1.6× 38 310
Kento Yoshioka Japan 9 21 0.2× 19 0.2× 8 0.1× 13 0.2× 83 2.0× 41 282
Christian Wallner Netherlands 10 138 1.3× 191 2.2× 18 0.3× 17 0.3× 75 1.8× 20 529
Sue McLennan Australia 6 13 0.1× 7 0.1× 42 0.7× 14 0.2× 119 2.8× 7 344
Pejvak Sassani United States 9 48 0.5× 58 0.7× 24 0.4× 10 0.2× 239 5.7× 13 397

Countries citing papers authored by Angelo Di Santo

Since Specialization
Citations

This map shows the geographic impact of Angelo Di Santo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Di Santo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Di Santo more than expected).

Fields of papers citing papers by Angelo Di Santo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Di Santo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Di Santo. The network helps show where Angelo Di Santo may publish in the future.

Co-authorship network of co-authors of Angelo Di Santo

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Di Santo. A scholar is included among the top collaborators of Angelo Di Santo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Di Santo. Angelo Di Santo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Santo, Angelo Di, Marco Canevelli, Daniele Belvisi, et al.. (2025). Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis. Neurological Sciences. 46(7). 3175–3182.
2.
Totani, Licia, Concetta Amore, Antônio Piccoli, et al.. (2021). Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis. Frontiers in Pharmacology. 12. 702677–702677. 18 indexed citations
3.
Grande, Pietro, et al.. (2019). Safety and efficacy of retroperitoneal sutureless zero ischemia laparoscopic partial nephrectomy for low nephrometry score masses. Archivio Italiano di Urologia e Andrologia. 91(3). 6 indexed citations
4.
Bianchi, Daniele, Angelo Di Santo, Gabriele Gaziev, et al.. (2014). Correlation between penile cuff test and pressure-flow study in patients candidates for trans-urethral resection of prostate. BMC Urology. 14(1). 103–103. 14 indexed citations
5.
Gaziev, Gabriele, Luca Topazio, Valerio Iacovelli, et al.. (2013). Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urology. 13(1). 61–61. 107 indexed citations
6.
Matteo, Vincenzo Di, Massimo Pierucci, Giuseppe Di Giovanni, et al.. (2006). Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: An in vivo microdialysis study. Brain Research. 1095(1). 167–177. 44 indexed citations
7.
Evangelista, Virgilio, Stefano Manarini, Angelo Di Santo, et al.. (2006). De Novo Synthesis of Cyclooxygenase-1 Counteracts the Suppression of Platelet Thromboxane Biosynthesis by Aspirin. Circulation Research. 98(5). 593–595. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026